TVRD — Tvardi Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Tvardi Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	181	167	145	101	37.9
Net Total Accounts Receivable
Net Total Receivables	2.06	1.15	4.45	4.02	4.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	195	173	169	116	43.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.12	3.6	1.98	8.19	0
Long Term Investments
Other Long Term Assets
Total Assets	271	247	182	126	43.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	18.5	17.6	23.5	25.6	3.97
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.2	19.5	23.5	68.8	48.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	249	228	159	57.1	-4.59
Total Liabilities & Shareholders' Equity	271	247	182	126	43.8
Total Common Shares Outstanding